✦ LIBER ✦

P517 Evaluating Adalimumab drug and antibody levels as predictors of clinical and laboratory response in Crohn's disease patients

✍ Scribed by Mazor, Y.; Koplov, U.; Ben Hur, D.; Almog, R.; Waterman, M.; Ben-Horin, S.; Chowers, Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tu1158 Evaluating Adalimumab Drug and An

✍ Mazor, Yoav; Kopylov, Uri; Ben Hur, Dana; Almog, Ronit; Waterman, Matti; Ben-Hor 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 51 KB

P563 Clinical response and quality of li

✍ Ceballos, D.; Muñoz, F.; Saro, C.; De la Coba, C.; Aguilar, M.D.; Lazaro, P. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 54 KB

P564 Clinical response, quality of life

✍ Saro, C.; Ceballos, D.; Muñoz, F.; De la Coba, C.; Aguilar, M.D.; Lazaro, P. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 65 KB

Adalimumab for Maintenance of Clinical R

✍ Jean–Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Robert Enns; Stephe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

P021 ADALIMUMAB TROUGH SERUM LEVELS AND

✍ K. Karmiris; G. Paintaud; D. Degenne; M. Ferrante; A. Duveau; M. Noman; G. Van A 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 76 KB

Effect of adalimumab on clinical laborat

✍ David T. Rubin; Parvez Mulani; Jingdong Chao; Paul F. Pollack; Arielle G. Bensim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB